EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

O uso do fumarato de vonoprazana na prevenção do esôfago de Barrett em pacientes com doença do refluxo gastroesofágico: uma revisão sistemática

Camilla Siqueira de Freitas Góis, João Lucas Souza Ferreira Almeida, Mariana Mahon Azevedo, Roberta Cavalcanti de Almeida

Revista ft · 10.11.2026 · 30 (164) · 01-12

DOI: 10.69849/hcjdjx42 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista ft, online erschienen am 10.11.2026. Verfasst von Camilla Siqueira de Freitas Góis und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastroesophageal reflux disease (GERD) is a chronic condition that can progress to Barrett's esophagus, a premalignant lesion associated with esophageal adenocarcinoma. Proton pump inhibitors (PPIs) are widely used but show limited long-term efficacy. In this context, vonoprazan, a potassium-competitive acid blocker (P-CAB), has emerged as a promising therapeutic alternative. This study is a qualitative, descriptive, and analytical systematic review that evaluated evidence on the efficacy of vonoprazan in preventing Barrett's esophagus in patients with GERD. Data were collected from PubMed and SciELO using DeCS/MeSH descriptors combined with Boolean operators, including studies published between 2015 and 2025 in Portuguese and English. Twelve studies met the inclusion criteria. The findings showed that vonoprazan achieved higher healing rates, longer symptom control, and lower recurrence of esophagitis compared with PPIs, with a favorable safety profile. It is concluded that vonoprazan is an effective and safe option for preventing the progression of GERD to Barrett's esophagus, although further long-term clinical studies are needed to confirm its therapeutic potential.

Zitieren

APA

Góis, C. S. D. F., Almeida, J. L. S. F., Azevedo, M. M., & Almeida, R. C. D. (2026). O uso do fumarato de vonoprazana na prevenção do esôfago de Barrett em pacientes com doença do refluxo gastroesofágico: uma revisão sistemática. Revista ft, 30(164), 01-12. https://doi.org/10.69849/hcjdjx42

Vancouver

Góis CSDF, Almeida JLSF, Azevedo MM, Almeida RCD. O uso do fumarato de vonoprazana na prevenção do esôfago de Barrett em pacientes com doença do refluxo gastroesofágico: uma revisão sistemática. Revista ft. 2026;30(164):01-12. doi:10.69849/hcjdjx42

BibTeX
@article{Gis2026,
  author = {Góis, Camilla Siqueira de Freitas and Almeida, João Lucas Souza Ferreira and Azevedo, Mariana Mahon and Almeida, Roberta Cavalcanti de},
  title = {O uso do fumarato de vonoprazana na prevenção do esôfago de Barrett em pacientes com doença do refluxo gastroesofágico: uma revisão sistemática},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {164},
  pages = {01--12},
  doi = {10.69849/hcjdjx42}
}
Kostenlos starten →